Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rate of breast biopsy referrals in female BRCA mutation carriers aged 50 years or more: a retrospective comparative study and matched analysis.
Pomerantz A, Tsoref D, Grubstein A, Wadhawker S, Rapson Y, Gadiel I, Goldvaser H, Feldhamer I, Hammerman A, Shochat T, Sharon E, Kedar I, Yerushalmi R. Pomerantz A, et al. Among authors: yerushalmi r. Breast Cancer Res Treat. 2022 Jun;193(2):507-514. doi: 10.1007/s10549-021-06498-9. Epub 2022 Apr 7. Breast Cancer Res Treat. 2022. PMID: 35391652 Free PMC article.
Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.
Margel D, Benjaminov O, Ozalvo R, Shavit Grievink L, Kedar I, Yerushalmi R, Ben-Aharon I, Neiman V, Yossepowitch O, Kedar D, Levy Z, Shohat M, Brenner B, Baniel J, Rosenbaum E. Margel D, et al. Among authors: yerushalmi r. BMC Cancer. 2014 Jul 21;14:528. doi: 10.1186/1471-2407-14-528. BMC Cancer. 2014. PMID: 25047061 Free PMC article. Clinical Trial.
Adjuvant Docetaxel and Cyclophosphamide (DC) with prophylactic granulocyte colony-stimulating factor (G-CSF) on days 8 &12 in breast cancer patients: a retrospective analysis.
Yerushalmi R, Goldvaser H, Sulkes A, Ben-Aharon I, Hendler D, Neiman V, Ciuraru NB, Bonilla L, Amit L, Zer A, Granot T, Rizel S, Stemmer SM. Yerushalmi R, et al. PLoS One. 2014 Oct 15;9(10):e107273. doi: 10.1371/journal.pone.0107273. eCollection 2014. PLoS One. 2014. PMID: 25330205 Free PMC article.
Malignancy associated SIADH: Characterization and clinical implications.
Goldvaser H, Rozen-Zvi B, Yerushalmi R, Gafter-Gvili A, Lahav M, Shepshelovich D. Goldvaser H, et al. Among authors: yerushalmi r. Acta Oncol. 2016 Sep-Oct;55(9-10):1190-1195. doi: 10.3109/0284186X.2016.1170198. Epub 2016 May 4. Acta Oncol. 2016. PMID: 27142293
Oncotype-DX recurrence score distribution in breast cancer patients with BRCA1/2 mutations.
Lewin R, Sulkes A, Shochat T, Tsoref D, Rizel S, Liebermann N, Hendler D, Neiman V, Ben-Aharon I, Friedman E, Paluch-Shimon S, Margel D, Kedar I, Yerushalmi R. Lewin R, et al. Among authors: yerushalmi r. Breast Cancer Res Treat. 2016 Jun;157(3):511-6. doi: 10.1007/s10549-016-3836-6. Epub 2016 May 25. Breast Cancer Res Treat. 2016. PMID: 27225387
219 results